Officials from 26 drug companies and 11 Latin American countries have reached an agreement that will slash the price of anti-HIV drugs in the region by as much as 66%, Inter Press Service reports. The price cuts will remain effective for two years, according to the agreement. The agreement will reduce the cost of antiretroviral therapy in Bolivia by 45%, in Uruguay by 48%, in Ecuador by 52%, in Chile by 56%, and in Paraguay by 66%. Price cuts also apply to Brazil, Peru, Venezuela, Colombia, Argentina, and Mexico. About 1.5 million people in Latin America are HIV-positive, but only 275,000 are currently taking anti-HIV medications. Officials in the Latin American countries say the price cuts on the drugs will enable them to significantly expand their HIV treatment programs.
Latin American
countries get discounts on anti-HIV drugs
countries get discounts on anti-HIV drugs















